Fulgent Genetics, Inc. (FLGT)
19.61
-0.34
(-1.70%)
USD |
NASDAQ |
Aug 28, 16:00
19.63
+0.02
(+0.10%)
After-Hours: 20:00
Fulgent Genetics Enterprise Value : 286.51M for Aug. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 286.51M |
| August 27, 2026 | 295.86M |
| August 26, 2026 | 292.01M |
| August 25, 2026 | 295.86M |
| August 24, 2026 | 282.10M |
| August 21, 2026 | 294.49M |
| August 20, 2026 | 295.04M |
| August 19, 2026 | 290.08M |
| August 18, 2026 | 257.89M |
| August 17, 2026 | 260.37M |
| August 14, 2026 | 257.62M |
| August 13, 2026 | 260.09M |
| August 12, 2026 | 261.74M |
| August 11, 2026 | 269.72M |
| August 10, 2026 | 271.37M |
| August 07, 2026 | 273.58M |
| August 06, 2026 | 257.34M |
| August 05, 2026 | 256.79M |
| August 04, 2026 | 257.34M |
| August 03, 2026 | 231.48M |
| July 31, 2026 | 202.31M |
| July 30, 2026 | 303.02M |
| July 29, 2026 | 287.33M |
| July 28, 2026 | 287.06M |
| July 27, 2026 | 285.68M |
| Date | Value |
|---|---|
| July 24, 2026 | 288.16M |
| July 23, 2026 | 296.69M |
| July 22, 2026 | 284.31M |
| July 21, 2026 | 293.94M |
| July 20, 2026 | 286.51M |
| July 17, 2026 | 301.64M |
| July 16, 2026 | 312.37M |
| July 15, 2026 | 325.03M |
| July 14, 2026 | 309.89M |
| July 13, 2026 | 308.79M |
| July 10, 2026 | 312.37M |
| July 09, 2026 | 321.45M |
| July 08, 2026 | 314.02M |
| July 07, 2026 | 325.30M |
| July 06, 2026 | 335.48M |
| July 02, 2026 | 320.63M |
| July 01, 2026 | 319.80M |
| June 30, 2026 | 311.55M |
| June 29, 2026 | 320.52M |
| June 26, 2026 | 304.08M |
| June 25, 2026 | 289.08M |
| June 24, 2026 | 280.13M |
| June 23, 2026 | 252.72M |
| June 22, 2026 | 242.91M |
| June 18, 2026 | 247.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 32.84B |
| Labcorp Holdings, Inc. | 33.75B |
| OPKO Health, Inc. | 1.201B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.612B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.72M |
| Revenue (Quarterly) | 85.39M |
| Total Expenses (Quarterly) | 114.92M |
| EPS Diluted (Quarterly) | -1.054 |
| Gross Profit Margin (Quarterly) | 27.02% |
| Profit Margin (Quarterly) | -34.80% |
| Earnings Yield | -14.43% |
| Normalized Earnings Yield | -13.77 |